78例原发性胆汁性肝硬化的临床分析

78例原发性胆汁性肝硬化的临床分析

论文摘要

目的 探讨原发性胆汁性肝硬化(PBC)的临床、免疫学及病理学特点,以提高对本病的认识、诊断和治疗。 方法 分析78例原发性胆汁性肝硬化患者的一般资料、临床表现、免疫学及病理学等改变,同时对其中19例患者进行肝组织学检查。 结果 本组患者中女性70例,确诊时平均年龄为46岁。发病至确诊时间为1—480月。确诊时有20例患者无典型临床症状(25.6%);有典型的皮肤瘙痒36例(46.2%)、肝脏肿大25例(32.1%)、脾脏肿大26例(33.3%)、有皮肤、巩膜黄染者64例(占82.13%)、ALP和GGT在疾病早期即明显升高,AMA阳性者为69例,约占88.5%;M2阳性59例,占75.6%,19例行肝穿刺检查的确诊患者中血清学检测均为阳性,UDCA治疗有效。 结论 我国PBC患者中也以女性为多,确诊时可无典型临床表现,如出现黄疸症状,预后差,进一步证实AMA-M2在PBC中的诊断作用,以及熊去氧胆酸在PBC中的治疗作用。

论文目录

  • 缩略语表
  • 中文摘要
  • 英文摘要
  • 前言
  • 78例原发性胆汁性肝硬化的临床分析
  • 材料和方法
  • 结果
  • 讨论
  • 参考文献
  • 综述:原发性胆汁性肝硬化的研究进展
  • 参考文献
  • 致谢
  • 相关论文文献

    • [1].Clinical characteristics and treatment outcomes in patients with liver cirrhosis and lymphoma[J]. World Journal of Hepatology 2020(02)
    • [2].Spontaneous porto-systemic shunts in liver cirrhosis: Clinical and therapeutical aspects[J]. World Journal of Gastroenterology 2020(15)
    • [3].Assessment of hemostatic profile in patients with mild to advanced liver cirrhosis[J]. World Journal of Gastroenterology 2020(17)
    • [4].Effect of zinc treatment on clinical outcomes in patients with liver cirrhosis:A systematic review and meta-analysis[J]. World Journal of Hepatology 2020(07)
    • [5].Prognostic Nomogram model for the efficacy of endoscopic treatment in gastric varices caused by liver cirrhosis[J]. China Medical Abstracts(Internal Medicine) 2020(02)
    • [6].Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients[J]. World Journal of Gastroenterology 2020(34)
    • [7].Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis[J]. World Journal of Gastroenterology 2019(03)
    • [8].The clinical characteristics and risk factors for acute kidney injury in patients with cirrhosis[J]. China Medical Abstracts(Internal Medicine) 2019(01)
    • [9].Novel non-invasive score to predict cirrhosis in the era of hepatitis C elimination: A population study of ex-substance users in Singapore[J]. Hepatobiliary & Pancreatic Diseases International 2019(02)
    • [10].Improving cirrhosis care: The potential for telemedicine and mobile health technologies[J]. World Journal of Gastroenterology 2019(29)
    • [11].Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity[J]. World Journal of Gastrointestinal Pathophysiology 2018(01)
    • [12].Clinical features of community-acquired bloodstream infection due to Gram-negative bacilli in patients with liver cirrhosis[J]. China Medical Abstracts(Internal Medicine) 2018(02)
    • [13].Efficacy and safety of autologous stem cell transplantation for decompensated liver cirrhosis: A retrospective cohort study[J]. World Journal of Stem Cells 2018(10)
    • [14].Is cirrhosis associated with lower odds of ischemic stroke:A nationwide analysis?[J]. World Journal of Hepatology 2016(35)
    • [15].Vasopressin use in critically ill cirrhosis patients with catecholamine-resistant septic shock: The CVICU cohort[J]. World Journal of Hepatology 2017(02)
    • [16].Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis[J]. World Journal of Gastroenterology 2017(08)
    • [17].Malnutrition negatively impacts the quality of life of patients with cirrhosis: An observational study[J]. World Journal of Hepatology 2017(05)
    • [18].Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis[J]. World Journal of Gastroenterology 2017(13)
    • [19].Effect of liver cirrhosis on long-term outcomes after acute respiratory failure: A population-based study[J]. World Journal of Gastroenterology 2017(12)
    • [20].Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis[J]. World Journal of Hepatology 2015(29)
    • [21].Bacterial infections in cirrhosis: A critical review and practical guidance[J]. World Journal of Hepatology 2016(06)
    • [22].Kallistatin,a new and reliable biomarker for the diagnosis of liver cirrhosis[J]. Acta Pharmaceutica Sinica B 2015(03)
    • [23].Presepsin teardown- pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis[J]. World Journal of Gastroenterology 2016(41)
    • [24].Non-invasive diagnosis of advanced fibrosis and cirrhosis[J]. World Journal of Gastroenterology 2014(45)
    • [25].Sarcopenia in the prognosis of cirrhosis: Going beyond the MELD score[J]. World Journal of Gastroenterology 2015(25)
    • [26].Portal vein thrombosis in cirrhosis: Controversies and latest developments[J]. World Journal of Gastroenterology 2015(22)
    • [27].Hepatitis C cirrhosis: New perspectives for diagnosis and treatment[J]. World Journal of Hepatology 2015(14)
    • [28].Prediction of liver cirrhosis, using diagnostic imaging tools[J]. World Journal of Hepatology 2015(17)
    • [29].Plasma betatrophin levels in patients with liver cirrhosis[J]. World Journal of Gastroenterology 2015(37)
    • [30].Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis[J]. World Journal of Hepatology 2015(22)

    标签:;  ;  ;  

    78例原发性胆汁性肝硬化的临床分析
    下载Doc文档

    猜你喜欢